{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:54:28Z","timestamp":1793652868806,"version":"4.5.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"8049","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,2,6]]},"DOI":"10.1038\/s41586-024-08439-0","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:04:34Z","timestamp":1737543874000},"page":"225-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":346,"title":["Immune evasion through mitochondrial transfer in the tumour microenvironment"],"prefix":"10.1038","volume":"638","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1334-7597","authenticated-orcid":false,"given":"Hideki","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6998-8481","authenticated-orcid":false,"given":"Katsushige","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4759-7871","authenticated-orcid":false,"given":"Tomofumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5341-6742","authenticated-orcid":false,"given":"Keizo","family":"Takenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Inozume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Ishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5787-2075","authenticated-orcid":false,"given":"Sho","family":"Aki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2627-8524","authenticated-orcid":false,"given":"Youki","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3870-2214","authenticated-orcid":false,"given":"Shinichiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8181-6241","authenticated-orcid":false,"given":"Hideki","family":"Makinoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Itami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-7410","authenticated-orcid":false,"given":"Yasutoshi","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6902-5386","authenticated-orcid":false,"given":"Yusuke","family":"Suenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Honobe-Tabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuyoshi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kiniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiki","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8787-5587","authenticated-orcid":false,"given":"Hidetoshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoyuki","family":"Hanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4645-0181","authenticated-orcid":false,"given":"Hiroyuki","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9479-6665","authenticated-orcid":false,"given":"Tsuyoshi","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4146-3629","authenticated-orcid":false,"given":"Masahito","family":"Kawazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9910-0164","authenticated-orcid":false,"given":"Yosuke","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"8439_CR1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331, 1565\u20131570 (2011).","journal-title":"Science"},{"key":"8439_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux, K. & Delgoffe, G. M. Metabolic barriers to cancer immunotherapy. Nat. Rev. Immunol. 21, 785\u2013797 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"8439_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping, N. E. et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45, 374\u2013388 (2016).","journal-title":"Immunity"},{"key":"8439_CR4","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"YR Yu","year":"2020","unstructured":"Yu, Y. R. et al. Disturbed mitochondrial dynamics in CD8. Nat. Immunol. 21, 1540\u20131551 (2020).","journal-title":"Nat. Immunol."},{"key":"8439_CR5","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u20132454 (2012).","journal-title":"N. Engl. J. Med."},{"key":"8439_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711\u2013723 (2010).","journal-title":"N. Engl. J. Med."},{"key":"8439_CR7","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer, J. R. et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366, 2455\u20132465 (2012).","journal-title":"N. Engl. J. Med."},{"key":"8439_CR8","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1111\/cas.15497","volume":"113","author":"J Nagasaki","year":"2022","unstructured":"Nagasaki, J., Ishino, T. & Togashi, Y. Mechanisms of resistance to immune checkpoint inhibitors. Cancer Sci. 113, 3303\u20133312 (2022).","journal-title":"Cancer Sci."},{"key":"8439_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"8439_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/ni.3704","volume":"18","author":"EL Mills","year":"2017","unstructured":"Mills, E. L., Kelly, B. & O\u2019Neill, L. A. J. Mitochondria are the powerhouses of immunity. Nat. Immunol. 18, 488\u2013498 (2017).","journal-title":"Nat. Immunol."},{"key":"8439_CR11","doi-asserted-by":"publisher","first-page":"e93411","DOI":"10.1172\/jci.insight.93411","volume":"2","author":"PJ Siska","year":"2017","unstructured":"Siska, P. J. et al. Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight 2, e93411 (2017).","journal-title":"JCI Insight"},{"key":"8439_CR12","doi-asserted-by":"publisher","first-page":"a012641","DOI":"10.1101\/cshperspect.a012641","volume":"5","author":"M Alexeyev","year":"2013","unstructured":"Alexeyev, M., Shokolenko, I., Wilson, G. & LeDoux, S. The maintenance of mitochondrial DNA integrity\u2014critical analysis and update. Cold Spring Harb. Perspect. Biol. 5, a012641 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"8439_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc3803","volume":"14","author":"SS Sabharwal","year":"2014","unstructured":"Sabharwal, S. S. & Schumacker, P. T. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles\u2019 heel? Nat. Rev. Cancer 14, 709\u2013721 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"8439_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41588-019-0557-x","volume":"52","author":"Y Yuan","year":"2020","unstructured":"Yuan, Y. et al. Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nat. Genet. 52, 342\u2013352 (2020).","journal-title":"Nat. Genet."},{"key":"8439_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00377-y","volume":"8","author":"JF Hopkins","year":"2017","unstructured":"Hopkins, J. F. et al. Mitochondrial mutations drive prostate cancer aggression. Nat. Commun. 8, 656 (2017).","journal-title":"Nat. Commun."},{"key":"8439_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s42255-021-00378-8","volume":"3","author":"AN Gorelick","year":"2021","unstructured":"Gorelick, A. N. et al. Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA. Nat. Metab. 3, 558\u2013570 (2021).","journal-title":"Nat. Metab."},{"key":"8439_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1126\/science.1156906","volume":"320","author":"K Ishikawa","year":"2008","unstructured":"Ishikawa, K. et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320, 661\u2013664 (2008).","journal-title":"Science"},{"key":"8439_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1073\/pnas.0408894102","volume":"102","author":"JA Petros","year":"2005","unstructured":"Petros, J. A. et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl Acad. Sci. USA 102, 719\u2013724 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8439_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s43018-023-00721-w","volume":"5","author":"M Mahmood","year":"2024","unstructured":"Mahmood, M. et al. Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma. Nat. Cancer 5, 659\u2013672 (2024).","journal-title":"Nat. Cancer"},{"key":"8439_CR20","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1073\/pnas.0510511103","volume":"103","author":"JL Spees","year":"2006","unstructured":"Spees, J. L., Olson, S. D., Whitney, M. J. & Prockop, D. J. Mitochondrial transfer between cells can rescue aerobic respiration. Proc. Natl Acad. Sci. USA 103, 1283\u20131288 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8439_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-023-06537-z","volume":"623","author":"N Borcherding","year":"2023","unstructured":"Borcherding, N. & Brestoff, J. R. The power and potential of mitochondria transfer. Nature 623, 283\u2013291 (2023).","journal-title":"Nature"},{"key":"8439_CR22","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.ccell.2023.09.003","volume":"41","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution. Cancer Cell 41, 1788\u20131802 (2023).","journal-title":"Cancer Cell"},{"key":"8439_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cmet.2014.12.003","volume":"21","author":"AS Tan","year":"2015","unstructured":"Tan, A. S. et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab. 21, 81\u201394 (2015).","journal-title":"Cell Metab."},{"key":"8439_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","volume":"17","author":"T Saha","year":"2022","unstructured":"Saha, T. et al. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat. Nanotechnol. 17, 98\u2013106 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"8439_CR25","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.cmet.2021.08.002","volume":"33","author":"C Crewe","year":"2021","unstructured":"Crewe, C. et al. Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes. Cell Metab. 33, 1853\u20131868 (2021).","journal-title":"Cell Metab."},{"key":"8439_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05077-9","volume":"9","author":"D Torralba","year":"2018","unstructured":"Torralba, D. et al. Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts. Nat. Commun. 9, 2658 (2018).","journal-title":"Nat. Commun."},{"key":"8439_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12860-021-00391-5","volume":"22","author":"K Takenaga","year":"2021","unstructured":"Takenaga, K., Koshikawa, N. & Nagase, H. Intercellular transfer of mitochondrial DNA carrying metastasis-enhancing pathogenic mutations from high- to low-metastatic tumor cells and stromal cells via extracellular vesicles. BMC Mol. Cell Biol. 22, 52 (2021).","journal-title":"BMC Mol. Cell Biol."},{"key":"8439_CR28","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.celrep.2016.09.054","volume":"17","author":"D Ebrahimi-Fakhari","year":"2016","unstructured":"Ebrahimi-Fakhari, D. et al. Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex. Cell Rep. 17, 1053\u20131070 (2016).","journal-title":"Cell Rep."},{"key":"8439_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s42003-024-05964-6","volume":"7","author":"C Chen","year":"2024","unstructured":"Chen, C., Li, H., Zhang, J. & Cheng, S. C. Exploring the limitations of mitochondrial dye as a genuine horizontal mitochondrial transfer surrogate. Commun. Biol. 7, 281 (2024).","journal-title":"Commun. Biol."},{"key":"8439_CR30","doi-asserted-by":"publisher","first-page":"1703244","DOI":"10.1080\/20013078.2019.1703244","volume":"9","author":"M Catalano","year":"2020","unstructured":"Catalano, M. & O\u2019Driscoll, L. Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J. Extracell. Vesicles 9, 1703244 (2020).","journal-title":"J. Extracell. Vesicles"},{"key":"8439_CR31","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1038\/onc.2011.636","volume":"31","author":"B Li","year":"2012","unstructured":"Li, B., Antonyak, M. A., Zhang, J. & Cerione, R. A. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene 31, 4740\u20134749 (2012).","journal-title":"Oncogene"},{"key":"8439_CR32","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jacc.2020.12.060","volume":"77","author":"G Ikeda","year":"2021","unstructured":"Ikeda, G. et al. Mitochondria-rich extracellular vesicles from autologous stem cell-derived cardiomyocytes restore energetics of ischemic myocardium. J. Am. Coll. Cardiol. 77, 1073\u20131088 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"8439_CR33","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.4161\/cc.9.17.12908","volume":"9","author":"B Chiavarina","year":"2010","unstructured":"Chiavarina, B. et al. HIF1-\u03b1 functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: autophagy drives compartment-specific oncogenesis. Cell Cycle 9, 3534\u20133551 (2010).","journal-title":"Cell Cycle"},{"key":"8439_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12860-016-0100-1","volume":"17","author":"Q Zhang","year":"2016","unstructured":"Zhang, Q. et al. Microvesicles derived from hypoxia\/reoxygenation-treated human umbilical vein endothelial cells promote apoptosis and oxidative stress in H9c2 cardiomyocytes. BMC Cell Biol. 17, 25 (2016).","journal-title":"BMC Cell Biol."},{"key":"8439_CR35","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/jcb.30312","volume":"123","author":"E Aryapour","year":"2022","unstructured":"Aryapour, E. & Kietzmann, T. Mitochondria, mitophagy, and the role of deubiquitinases as novel therapeutic targets in liver pathology. J. Cell. Biochem. 123, 1634\u20131646 (2022).","journal-title":"J. Cell. Biochem."},{"key":"8439_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb3097","volume":"17","author":"CN Cunningham","year":"2015","unstructured":"Cunningham, C. N. et al. USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria. Nat. Cell Biol. 17, 160\u2013169 (2015).","journal-title":"Nat. Cell Biol."},{"key":"8439_CR37","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature13418","volume":"510","author":"B Bingol","year":"2014","unstructured":"Bingol, B. et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 510, 370\u2013375 (2014).","journal-title":"Nature"},{"key":"8439_CR38","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1080\/15548627.2019.1656957","volume":"16","author":"K Niu","year":"2020","unstructured":"Niu, K. et al. USP33 deubiquitinates PRKN\/parkin and antagonizes its role in mitophagy. Autophagy 16, 724\u2013734 (2020).","journal-title":"Autophagy"},{"key":"8439_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/15548627.2015.1034408","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Deubiquitinating enzymes regulate PARK2-mediated mitophagy. Autophagy 11, 595\u2013606 (2015).","journal-title":"Autophagy"},{"key":"8439_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41580-021-00342-0","volume":"22","author":"T Suzuki","year":"2021","unstructured":"Suzuki, T. The expanding world of tRNA modifications and their disease relevance. Nat. Rev. Mol. Cell Biol. 22, 375\u2013392 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"8439_CR41","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/nar\/gky068","volume":"46","author":"K Asano","year":"2018","unstructured":"Asano, K. et al. Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease. Nucleic Acids Res. 46, 1565\u20131583 (2018).","journal-title":"Nucleic Acids Res."},{"key":"8439_CR42","doi-asserted-by":"publisher","first-page":"e23401","DOI":"10.1371\/journal.pone.0023401","volume":"6","author":"H Imanishi","year":"2011","unstructured":"Imanishi, H. et al. Mitochondrial DNA mutations regulate metastasis of human breast cancer cells. PLoS ONE 6, e23401 (2011).","journal-title":"PLoS ONE"},{"key":"8439_CR43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","volume":"120","author":"RS Balaban","year":"2005","unstructured":"Balaban, R. S., Nemoto, S. & Finkel, T. Mitochondria, oxidants, and aging. Cell 120, 483\u2013495 (2005).","journal-title":"Cell"},{"key":"8439_CR44","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1158\/0008-5472.CAN-04-2012","volume":"65","author":"Y Shidara","year":"2005","unstructured":"Shidara, Y. et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 65, 1655\u20131663 (2005).","journal-title":"Cancer Res."},{"key":"8439_CR45","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani, E. T. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431\u2013435 (2014).","journal-title":"Nature"},{"key":"8439_CR46","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cmet.2016.03.009","volume":"23","author":"F Scial\u00f2","year":"2016","unstructured":"Scial\u00f2, F. et al. Mitochondrial ROS produced via reverse electrontransport extend animal lifespan. Cell Metab. 23, 725\u2013734 (2016).","journal-title":"Cell Metab."},{"key":"8439_CR47","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.aax0860","volume":"368","author":"G Desd\u00edn-Mic\u00f3","year":"2020","unstructured":"Desd\u00edn-Mic\u00f3, G. et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science 368, 1371\u20131376 (2020).","journal-title":"Science"},{"key":"8439_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","volume":"36","author":"GJ van der Windt","year":"2012","unstructured":"van der Windt, G. J. et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36, 68\u201378 (2012).","journal-title":"Immunity"},{"key":"8439_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/srep09073","volume":"5","author":"A Caicedo","year":"2015","unstructured":"Caicedo, A. et al. MitoCeption as a new tool to assess the effects of mesenchymal stem\/stromal cell mitochondria on cancer cell metabolism and function. Sci. Rep. 5, 9073 (2015).","journal-title":"Sci. Rep."},{"key":"8439_CR50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","volume":"27","author":"NS Joshi","year":"2007","unstructured":"Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281\u2013295 (2007).","journal-title":"Immunity"},{"key":"8439_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417\u2013421 (2016).","journal-title":"Nature"},{"key":"8439_CR52","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature19317","volume":"537","author":"R He","year":"2016","unstructured":"He, R. et al. Follicular CXCR5- expressing CD8+ T cells curtail chronic viral infection. Nature 537, 412\u2013428 (2016).","journal-title":"Nature"},{"key":"8439_CR53","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/sj.jid.5700099","volume":"126","author":"KJ Krishnan","year":"2006","unstructured":"Krishnan, K. J. & Birch-Machin, M. A. The incidence of both tandem duplications and the common deletion in mtDNA from three distinct categories of sun-exposed human skin and in prolonged culture of fibroblasts. J. Invest. Dermatol. 126, 408\u2013415 (2006).","journal-title":"J. Invest. Dermatol."},{"key":"8439_CR54","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/s41588-018-0264-z","volume":"50","author":"DC Wallace","year":"2018","unstructured":"Wallace, D. C. Mitochondrial genetic medicine. Nat. Genet. 50, 1642\u20131649 (2018).","journal-title":"Nat. Genet."},{"key":"8439_CR55","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","volume":"23","author":"EI Buzas","year":"2023","unstructured":"Buzas, E. I. The roles of extracellular vesicles in the immune system. Nat. Rev. Immunol. 23, 236\u2013250 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"8439_CR56","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1101\/gr.250480.119","volume":"29","author":"R O\u2019Hara","year":"2019","unstructured":"O\u2019Hara, R. et al. Quantitative mitochondrial DNA copy number determination using droplet digital PCR with single-cell resolution. Genome Res. 29, 1878\u20131888 (2019).","journal-title":"Genome Res."},{"key":"8439_CR57","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc3262","volume":"12","author":"E White","year":"2012","unstructured":"White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 12, 401\u2013410 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"8439_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41785-7","volume":"14","author":"YS Hong","year":"2023","unstructured":"Hong, Y. S. et al. Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality. Nat. Commun. 14, 6113 (2023).","journal-title":"Nat. Commun."},{"key":"8439_CR59","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nrg3966","volume":"16","author":"JB Stewart","year":"2015","unstructured":"Stewart, J. B. & Chinnery, P. F. The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nat. Rev. Genet. 16, 530\u2013542 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"8439_CR60","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.jid.2019.01.007","volume":"139","author":"T Inozume","year":"2019","unstructured":"Inozume, T. et al. Analysis of the tumor reactivity of tumor-infiltrating lymphocytes in a metastatic melanoma lesion that lost MHC class I expression after anti-PD-1 therapy. J. Invest. Dermatol. 139, 1490\u20131496 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"8439_CR61","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6, 80\u201392 (2012).","journal-title":"Fly"},{"key":"8439_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-018-0342-1","volume":"11","author":"T Kuo","year":"2018","unstructured":"Kuo, T., Frith, M. C., Sese, J. & Horton, P. EAGLE: explicit alternative genome likelihood evaluator. BMC Med. Genomics 11, 28 (2018).","journal-title":"BMC Med. Genomics"},{"key":"8439_CR63","doi-asserted-by":"publisher","first-page":"W58","DOI":"10.1093\/nar\/gkw233","volume":"44","author":"H Weissensteiner","year":"2016","unstructured":"Weissensteiner, H. et al. HaploGrep 2: mitochondrial haplogroup classification in the era of high-throughput sequencing. Nucleic Acids Res. 44, W58\u2013W63 (2016).","journal-title":"Nucleic Acids Res."},{"key":"8439_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.418","volume":"7","author":"M Akimoto","year":"2016","unstructured":"Akimoto, M., Hayashi, J. I., Nakae, S., Saito, H. & Takenaga, K. Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer. Cell Death Dis. 7, e2057 (2016).","journal-title":"Cell Death Dis."},{"key":"8439_CR65","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.onc.1200820","volume":"14","author":"K Takenaga","year":"1997","unstructured":"Takenaga, K., Nakamura, Y. & Sakiyama, S. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene 14, 331\u2013337 (1997).","journal-title":"Oncogene"},{"key":"8439_CR66","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/sj.gt.3301433","volume":"8","author":"SS Diebold","year":"2001","unstructured":"Diebold, S. S., Cotten, M., Koch, N. & Zenke, M. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Gene Ther. 8, 487\u2013493 (2001).","journal-title":"Gene Ther."},{"key":"8439_CR67","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/nar\/18.12.3587","volume":"18","author":"JP Morgenstern","year":"1990","unstructured":"Morgenstern, J. P. & Land, H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587\u20133596 (1990).","journal-title":"Nucleic Acids Res."},{"key":"8439_CR68","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/hmg\/ddt009","volume":"22","author":"BM Kitay","year":"2013","unstructured":"Kitay, B. M., McCormack, R., Wang, Y., Tsoulfas, P. & Zhai, R. G. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT\/WLD(S)-mediated axon protection independent of axonal mitochondria. Hum. Mol. Genet. 22, 1601\u20131614 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"8439_CR69","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463\u20138471 (1998).","journal-title":"J. Virol."},{"key":"8439_CR70","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).","journal-title":"J. Extracell. Vesicles"},{"key":"8439_CR71","doi-asserted-by":"publisher","first-page":"eabq2226","DOI":"10.1126\/sciadv.abq2226","volume":"8","author":"J Sanz-Ros","year":"2022","unstructured":"Sanz-Ros, J. et al. Small extracellular vesicles from young adipose-derived stem cells prevent frailty, improve health span, and decrease epigenetic age in old mice. Sci. Adv. 8, eabq2226 (2022).","journal-title":"Sci. Adv."},{"key":"8439_CR72","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.4049\/jimmunol.2200596","volume":"210","author":"JN Keeney","year":"2023","unstructured":"Keeney, J. N., Winters, A. D., Sitcheran, R. & West, A. P. NF-\u03baB-inducing kinase governs the mitochondrial respiratory capacity, differentiation, and inflammatory status of innate immune cells. J. Immunol. 210, 1123\u20131133 (2023).","journal-title":"J. Immunol."},{"key":"8439_CR73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2020.06.016","volume":"53","author":"S Kumagai","year":"2020","unstructured":"Kumagai, S. et al. An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T cells. Immunity 53, 187\u2013203.e188 (2020).","journal-title":"Immunity"},{"key":"8439_CR74","doi-asserted-by":"publisher","unstructured":"jlincbio. jlincbio\/mito_somatic_mutect2: release update (v0.3). Zenodo https:\/\/doi.org\/10.5281\/zenodo.12216418 (2024).","DOI":"10.5281\/zenodo.12216418"}],"updated-by":[{"DOI":"10.1038\/s41586-025-08764-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000}},{"DOI":"10.1038\/s41586-025-09408-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08439-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08439-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08439-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T05:54:14Z","timestamp":1757138054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08439-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":74,"journal-issue":{"issue":"8049","published-print":{"date-parts":[[2025,2,6]]}},"alternative-id":["8439"],"URL":"https:\/\/doi.org\/10.1038\/s41586-024-08439-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-025-09408-x","URL":"https:\/\/doi.org\/10.1038\/s41586-025-09408-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-025-08764-y","URL":"https:\/\/doi.org\/10.1038\/s41586-025-08764-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.\u2009Inozume. received honoraria from Ono Pharmaceutical, Bristol-Myers Squibb and MSD outside this study. S.S. received honoraria from AstraZeneca outside this study. Yasuhiro Nakamura. received honoraria from Ono Pharmaceutical and Novartis Pharma outside this study. E.I. received grants from Janssen Pharmaceutical, Bristol-Myers Squibb, Takeda Pharmaceutical, Pfizer Japan and Ono Pharmaceutical; honoraria from AstraZeneca, Novartis Pharma, Janssen Pharmaceutical, Boehringer Ingelheim, Chugai Pharmaceutical, Eli Lilly Japan and Pfizer Japan outside this study. H.H. received research grants from AstraZeneca, Astellas Pharma, MSD, Ono Pharmaceutical, Nippon Boehringer Ingelheim, Novartis Pharma, Pfizer Japan, Bristol-Myers Squibb, Eli Lilly Japan, Chugai Pharmaceutical, Daiichi Sankyo, Merck Serono, Merck Biopharma, Takeda Pharmaceutical, Taiho Pharmaceutical, SymBio Pharmaceuticals, AbbVie, inVentiv Health Japan, ICON Japan, Gritstone Oncology, Parexel International, Kissei Pharmaceutical, EPS, Syneos Health, Pfizer R&D Japan, A2 Healthcare, Quintiles\/IQVIA Services Japan, EP-CRSU, Linical, Eisai, CMIC Shift Zero, Kyowa Hakko Kirin, Bayer Yakuhin, EPS International and Otsuka Pharmaceutical; honoraria from Amgen, AstraZeneca, Boehringer Ingelheim Japan, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Eli Lilly Japan, Janssen Pharmaceutical, Kyorin Pharmaceutical, Merck Biopharma, MSD, Novartis Pharmaceuticals, Ono Pharmaceutical, Taiho Pharmaceutical and Takeda Pharmaceutical; consulting fees from AstraZeneca, Boehringer Ingelheim Japan, Bristol-Myers Squibb, Chugai Pharmaceutical, Eli Lilly Japan, Guardant Health, Pfizer Japan, Shanghai Haihe Biopharma, Takeda Pharmaceutical and Merck Biopharma outside this study. Y.\u2009Togashi received research grants from KOTAI Biotechnologies, Daiichi-Sankyo, Ono Pharmaceutical, Bristol-Myers Squibb and KORTUC, and honoraria from Ono Pharmaceutical, Bristol-Myers Squibb, AstraZeneca, Chugai Pharmaceutical and MSD outside this study. All other authors declare that they have no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}